Cargando...
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
BACKGROUND: Rituximab is a promising steroid sparing agent used in the treatment of moderate to severe pemphigus vulgaris. Its exact place in the algorithm of pemphigus treatment, vis-à-vis other, conventional adjuvant therapy (CAT) is not known. OBJECTIVE: To describe and compare disease course out...
Gardado en:
| Publicado en: | PLoS One |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6155499/ https://ncbi.nlm.nih.gov/pubmed/30252855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0198074 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|